154 related articles for article (PubMed ID: 7535056)
21. Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards.
Turner PR; Denny WA; Ferguson LR
Anticancer Drug Des; 2000 Aug; 15(4):245-53. PubMed ID: 11200500
[TBL] [Abstract][Full Text] [Related]
22. Isohelicity and phasing in drug--DNA sequence recognition: crystal structure of a tris(benzimidazole)--oligonucleotide complex.
Clark GR; Gray EJ; Neidle S; Li YH; Leupin W
Biochemistry; 1996 Oct; 35(43):13745-52. PubMed ID: 8901516
[TBL] [Abstract][Full Text] [Related]
23. RecA-catalyzed, sequence-specific alkylation of DNA by cross-linking oligonucleotides. Effects of length and nonhomologous base substitutions.
Podyminogin MA; Meyer RB; Gamper HB
Biochemistry; 1996 Jun; 35(22):7267-74. PubMed ID: 8679556
[TBL] [Abstract][Full Text] [Related]
24. DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258).
Gravatt GL; Baguley BC; Wilson WR; Denny WA
J Med Chem; 1994 Dec; 37(25):4338-45. PubMed ID: 7527862
[TBL] [Abstract][Full Text] [Related]
25. Synthetic analogues of netropsin and distamycin. I. Pyridine-containing analogues of distamycin--a molecular modelling study.
Bielawski K; Bartulewicz D; Rózański A
Rocz Akad Med Bialymst; 1995; 40(2):352-63. PubMed ID: 8834619
[TBL] [Abstract][Full Text] [Related]
26. Sequence-selective targeting of long stretches of the DNA minor groove by a novel dimeric bis-benzimidazole.
Joubert A; Sun XW; Johansson E; Bailly C; Mann J; Neidle S
Biochemistry; 2003 May; 42(20):5984-92. PubMed ID: 12755600
[TBL] [Abstract][Full Text] [Related]
27. Sequence-specific DNA minor groove binders. Design and synthesis of netropsin and distamycin analogues.
Bailly C; Chaires JB
Bioconjug Chem; 1998; 9(5):513-38. PubMed ID: 9736486
[No Abstract] [Full Text] [Related]
28. Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity.
Wyatt MD; Lee M; Garbiras BJ; Souhami RL; Hartley JA
Biochemistry; 1995 Oct; 34(40):13034-41. PubMed ID: 7548062
[TBL] [Abstract][Full Text] [Related]
29. DNA sequence dependent monomer-dimer binding modulation of asymmetric benzimidazole derivatives.
Tanious FA; Hamelberg D; Bailly C; Czarny A; Boykin DW; Wilson WD
J Am Chem Soc; 2004 Jan; 126(1):143-53. PubMed ID: 14709078
[TBL] [Abstract][Full Text] [Related]
30. Bis-benzimidazole anticancer agents: targeting human tumour helicases.
Soderlind KJ; Gorodetsky B; Singh AK; Bachur NR; Miller GG; Lown JW
Anticancer Drug Des; 1999 Feb; 14(1):19-36. PubMed ID: 10363025
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxics derived from distamycin A and congeners.
Cozzi P; Mongelli N
Curr Pharm Des; 1998 Jun; 4(3):181-201. PubMed ID: 10197039
[TBL] [Abstract][Full Text] [Related]
32. Cooperative alkylation by duocarmycin A-distamycin A heterodimer.
Ozeki Y; Sugiyama H; Saito I
Nucleic Acids Symp Ser; 1997; (37):91-2. PubMed ID: 9586014
[TBL] [Abstract][Full Text] [Related]
33. Backbone and benzoyl mustard carrying moiety modifies DNA interactions of distamycin analogues.
Ciucci A; Manzini S; Lombardi P; Arcamone F
Nucleic Acids Res; 1996 Jan; 24(2):311-5. PubMed ID: 8628655
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, DNA binding, sequence preference and biological evaluation of minor groove-selective N1-alkoxyalkyl-bis-benzimidazoles.
Wang H; Gupta R; Lown JW
Anticancer Drug Des; 1994 Jun; 9(3):153-60. PubMed ID: 8031450
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and reactivity of aryl nitrogen mustard-oligodeoxyribonucleotide conjugates.
Reed MW; Lukhtanov EA; Gorn V; Kutyavin I; Gall A; Wald A; Meyer RB
Bioconjug Chem; 1998; 9(1):64-71. PubMed ID: 9460548
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and DNA interactions of benzimidazole dications which have activity against opportunistic infections.
Lombardy RL; Tanious FA; Ramachandran K; Tidwell RR; Wilson WD
J Med Chem; 1996 Mar; 39(7):1452-62. PubMed ID: 8691476
[TBL] [Abstract][Full Text] [Related]
37. Recent developments in sequence selective minor groove DNA effectors.
Reddy BS; Sharma SK; Lown JW
Curr Med Chem; 2001 Apr; 8(5):475-508. PubMed ID: 11281837
[TBL] [Abstract][Full Text] [Related]
38. Combinatorial identification of a novel consensus sequence for the covalent DNA-binding polyamide tallimustine.
Sunavala-Dossabhoy G; Van Dyke MW
Biochemistry; 2005 Feb; 44(7):2510-22. PubMed ID: 15709763
[TBL] [Abstract][Full Text] [Related]
39. A prototype bioreductive DNA groove binding ligand.
Haworth IS; Burt C; Gago F; Reynolds CA; Richards WG
Anticancer Drug Des; 1991 Feb; 6(1):59-70. PubMed ID: 1707627
[TBL] [Abstract][Full Text] [Related]
40. Determination of microscopic binding constants at individual DNA base sequences for the minor groove binders Hoechst 33258, DAPI and pentamidine.
Matesoi D; Kittler L; Bell A; Unger E; Lober G
Biochem Mol Biol Int; 1996 Feb; 38(1):123-32. PubMed ID: 8932526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
